Turnstone Biologics Corp.
TSBX
$0.35
$0.0319.72%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -28.33% | -41.97% | -45.76% | -312.66% | -79.02% |
| Total Depreciation and Amortization | -34.42% | -35.11% | -36.00% | -33.37% | -28.27% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -63.64% | -81.06% | -78.43% | -77.08% | -69.85% |
| Change in Net Operating Assets | 100.26% | 116.48% | 107.88% | 103.80% | 69.08% |
| Cash from Operations | -1.94% | 5.26% | -6.77% | 7.43% | 6.91% |
| Capital Expenditure | 81.67% | 81.64% | 85.06% | 90.56% | 75.84% |
| Sale of Property, Plant, and Equipment | -94.47% | 65.00% | 47.15% | 147.69% | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 388.54% | 428.33% | -226.24% | -499.14% | -179.61% |
| Cash from Investing | 379.62% | 405.99% | -278.81% | -1,434.12% | -88.14% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -99.94% | -99.94% | 83,847.31% | 33,826.09% | 49,653.50% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 96.33% | 96.33% | 104.45% | 100.00% | 68.08% |
| Cash from Financing | -99.99% | -100.20% | 2,108.72% | 2,336.74% | 3,000.83% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 164.70% | -47.55% | 93.02% | 73.85% | 80.60% |